LAC Med Berhad (KLSE:LACMED)

LAC Med Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	24.39	30.55	15.84	30.45	23.83
Short-Term Investments	46.44	52.49	27.74	2.94	0.95
Cash & Short-Term Investments	70.83	83.04	43.58	33.39	24.77
Cash Growth	62.51%	90.52%	30.51%	34.80%	-
Accounts Receivable	87.19	80.14	38.74	68.73	50.96
Other Receivables	10.81	1.13	0.42	0.38	0.29
Receivables	98	81.27	39.16	69.11	51.24
Inventory	29.17	27.78	20.8	21.61	10.84
Prepaid Expenses	-	0.67	0.42	0.13	0.08
Other Current Assets	-	7.79	20.02	11.88	14.08
Total Current Assets	197.99	200.54	123.99	136.12	101.02
Property, Plant & Equipment	12.45	9.81	1.46	1.36	0.6
Other Intangible Assets	2.69	2.83	-	-	-
Long-Term Deferred Tax Assets	2.04	2.04	2.66	2.13	1.63
Total Assets	215.18	215.23	128.11	139.61	103.25

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Accounts Payable	39.83	38.6	28.74	37.53	19.28
Accrued Expenses	-	5.34	3.62	4.16	1.42
Short-Term Debt	-	20.93	18.15	22.43	31.25
Current Portion of Long-Term Debt	24.79	0.17	0.77	0.82	0.77
Current Portion of Leases	1.12	0.17	0.11	0.15	0.12
Current Income Taxes Payable	-0.04	2.91	2.1	1.84	1.99
Current Unearned Revenue	7.61	7.47	13.96	16.36	12.22
Other Current Liabilities	17.21	19.55	11.36	14.2	7.98
Total Current Liabilities	90.52	95.15	78.81	97.47	75.02
Long-Term Debt	1.02	1.07	1.3	2.06	2.88
Long-Term Leases	3.69	0.11	0.1	0.21	0.23
Total Liabilities	95.28	96.32	80.21	99.75	78.13

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Common Stock	102.2	102.2	2	2	2
Retained Earnings	63.78	62.75	45.77	37.87	23.12
Comprehensive Income & Other	-46.12	-46.11	-0	-	-
Total Common Equity	119.86	118.84	47.76	39.87	25.12
Minority Interest	0.04	0.06	0.14	-	-
Shareholders' Equity	119.9	118.91	47.9	39.87	25.12
Total Liabilities & Equity	215.18	215.23	128.11	139.61	103.25

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Total Debt	30.62	22.45	20.42	25.67	35.24
Net Cash (Debt)	40.21	60.58	23.16	7.72	-10.47
Net Cash Growth	73.59%	161.57%	199.90%	-	-
Net Cash Per Share	0.19	0.52	11.58	3.86	-5.23
Filing Date Shares Outstanding	400	400	2	2	2
Total Common Shares Outstanding	400	400	2	2	2
Working Capital	107.48	105.4	45.17	38.65	26
Book Value Per Share	0.30	0.30	23.88	19.93	12.56
Tangible Book Value	117.17	116.01	47.76	39.87	25.12
Tangible Book Value Per Share	0.29	0.29	23.88	19.93	12.56
Machinery	-	11.15	2.05	1.67	1.17
Order Backlog	-	216.7	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 10, 2026

Data Sources Report a data error